BridgeBio to stop development of therapy for genetic disorder, ET HealthWorld

London: BridgeBio Pharma said on Tuesday it will stop development of its experimental therapy for a genetic disease that affects the adrenaline-producing gland.

The drugmaker said the results of its early-to-mid stage study testing the therapy did not meet the threshold to warrant additional capital investment.

It will reduce its gene therapy development budget by more than $50 million, and seek partnership opportunities to support future development of the therapy, BBP-631, or newer treatments for congenital adrenal hyperplasia (CAH).

CAH is a group of genetic disorders caused by a mutation in an enzyme needed to produce cortisol, which is secreted by the adrenal gland.

The study showed that higher doses of BBP-631 increased production of cortisol in all patients.

Cortisol helps the body to respond to injury, stress or illness.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)

Published On Sep 11, 2024 at 10:45 PM IST

Be the first one to comment.

Comment Now

All Comments

</p>
<p class="comment-policy btn-post-comment hide">By commenting, you agree to the <a rel="nofollow noopener" target="_blank" class="link" href="https://health.economictimes.indiatimes.com/terms_conditions.php#prohibited_cnt">Prohibited Content Policy</a></p>
<p>                                <a rel="nofollow" class="btn btn-post-comment hide" tabindex="0" role="button" onclick="EtB2b.comments.addComments(this)">Post</a>
                            </div>
<div class="post-comment-section mobile-view">
                                <textarea id="" onkeyup="EtB2b.comments.handleTextAreaEvents(this)" placeholder="What are your thoughts?" class="write-comment"/></p>
<p class="comment-policy btn-post-comment hide">By commenting, you agree to the <a rel="nofollow noopener" target="_blank" class="link" href="https://health.economictimes.indiatimes.com/terms_conditions.php#prohibited_cnt">Prohibited Content Policy</a></p>
<p>                                <a rel="nofollow" class="btn btn-post-comment hide" tabindex="0" role="button">Post</a>
                            </div>
</p></div>
<div class="comment-report-container hide" comment-id="">
<h2>Find this Comment Offensive?</h2>
<p>                            <span class="txt-synps">Choose your reason below and click on the submit button. This will alert our moderators to take actions</span></p>
<p>REASONS FOR REPORTING</p>
<ul class="resport-options">
<li>
                                    <input type="radio" id="cm_lang" name="language" value="Foul Language"/><br />
                                    <label for="cm_lang">Foul Language</label>
                                </li>
<li>
                                    <input type="radio" id="cm_defamatory" name="language" value="Defamatory"/><br />
                                    <label for="cm_defamatory">Defamatory</label>
                                </li>
<li>
                                    <input type="radio" id="cm_community" name="language" value="Community"/><br />
                                    <label for="cm_community">Inciting hatred against a certain community</label>
                                </li>
<li>
                                    <input type="radio" id="cm_spam" name="language" value="Out of Context / Spam"/><br />
                                    <label for="cm_spam">Out of Context / Spam</label>
                                </li>
<li>
                                    <input type="radio" id="cm_others" name="language" value="Others"/><br />
                                    <label for="cm_others">Others</label>
                                </li>
</ul>
<p>                            <button onclick="EtB2b.comments.commentFlagged(this)" class="btn btn-invert">Report</button>
                        </div>
</p></div>
</p></div>
</p></div>
<p>               </p>
<div class="subscription-in-article">
<div aria-label="Top Newsletter Subscription Section" class="top-newsletter-subs">
<div class="subscription-section hide">
<div class="inner-subscription">
<p><h2>Join the community of 2M+ industry professionals</h2>
<h3>Subscribe to our newsletter to get latest insights & analysis.</h3>
</p>
<figure class="top-newsletter-subs__icon-nl" role="presentation" aria-label="Newsletter icon">
                <img decoding="async" loading="lazy" src="https://st.etb2bimg.com/Themes/Release/theme4/images/icons/icon-newsletter.svg" alt="Newsletter icon" width="55" height="55"/><br />
            </figure>
</p></div>
<form action="#" class="top-newsletter-subs__form">
            <input type="text" id="subscribe_email_top" placeholder="Your Email" class="input-box top-newsletter-subs__input-box"/><br />
            <input id="subscriber_btn_top" type="button" value="Subscribe For Free" onclick="EtB2b.subscription.updateSubscription('top');" class="btn top-newsletter-subs__submit btn-variation"/><br />
        </form>
</p></div>
<div class="app-download-section hide">
<div class="inner-app-download">
<div>
<h2>Download ETHealthworld App </h2>
<ul>
<li>Get Realtime updates</li>
<li>Save your favourite articles</li>
</ul>
<div class="app-store-container desktop-view">
                            <a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/app" title="" aria-label="Play Store" target="_blank"><br />
                                <img decoding="async" loading="lazy" width="20" height="20" src="https://st.etb2bimg.com/Themes/Release/theme4/images/icons/icon-g-play.png" alt=""/><br />
                            </a><br />
                            <a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/app" title="App Store" target="_blank"><br />
                                <img decoding="async" loading="lazy" width="20" height="20" src="https://st.etb2bimg.com/Themes/Release/theme4/images/icons/icon-app-store.png" alt=""/><br />
                            </a>
                        </div>
</p></div>
<figure class="download-icon desktop-view">
                        <i/><br />
                        <span class="scan-text">Scan to download App</span><br />
                        <img decoding="async" loading="lazy" width="90" height="90" src="https://st.etb2bimg.com/Themes/Release/theme4/images/bar-codes/health_barcode.png?mod=2672" alt=""/><br />
                        <span class="border-bottom"/><br />
                    </figure>
</p></div>
</p></div>
</div></div>
<div class="article-section__body__news__tags">
<div class="breadcrumbs_scrollable_x">
<div class="breadcrumbs">
<ul class="news-tags-article">
                        </p>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/experimental+therapy+for+a+genetic" title="experimental therapy for a genetic" target="_blank">experimental therapy for a genetic</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/affects+the+adrenaline-producing+gland" title="affects the adrenaline-producing gland" target="_blank">affects the adrenaline-producing gland</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/warrant+additional+capital+investment" title="warrant additional capital investment" target="_blank">warrant additional capital investment</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/gene+therapy+development+budget" title="gene therapy development budget" target="_blank">gene therapy development budget</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/opportunities+to+support+future+development" title="opportunities to support future development" target="_blank">opportunities to support future development</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/treatments+for+congenital+adrenal+hyperplasia" title="treatments for congenital adrenal hyperplasia" target="_blank">treatments for congenital adrenal hyperplasia</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/cah+is+a+group+of+genetic+disorders" title="CAH is a group of genetic disorders" target="_blank">CAH is a group of genetic disorders</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/nzyme+needed+to+produce+cortisol" title="nzyme needed to produce cortisol" target="_blank">nzyme needed to produce cortisol</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/higher+doses+of+bbp-631+increased" title="higher doses of BBP-631 increased" target="_blank">higher doses of BBP-631 increased</a></li>
<li><a rel="nofollow noopener" href="https://health.economictimes.indiatimes.com/tag/health+news" title="Health news" target="_blank">Health news</a></li>
</ul></div>
</p></div>
</p></div>
</p></div>

<div id="respond" class="comment-respond">
		<h3 id="reply-title" class="comment-reply-title">Leave a Reply <small><a rel="nofollow" id="cancel-comment-reply-link" href="/bridgebio-to-stop-development-of-therapy-for-genetic-disorder-et-healthworld/#respond" style="display:none;">Cancel reply</a></small></h3><form action="https://www.technologydekho.com/wp-comments-post.php" method="post" id="commentform" class="comment-form" novalidate><p class="comment-notes"><span id="email-notes">Your email address will not be published.</span> <span class="required-field-message">Required fields are marked <span class="required">*</span></span></p><p class="comment-form-comment"><label for="comment">Comment <span class="required">*</span></label> <textarea id="comment" name="comment" cols="45" rows="8" maxlength="65525" required>

Name *

Email *

Website

BridgeBio to stop development of therapy for genetic disorder, ET HealthWorld

ByShivam Sharma

COMMENTS

You missed

The iPhone 16 launches today without its most hyped feature: Apple Intelligence

49ers’ Kittle doubtful at Rams; Bosa, Ward questionable

रवनीत सिंह बिट्टू को कांग्रेस विधायक की सिर कलम करने की धमकी, देखें ‘पंजाब आजतक’